Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian

Clinical trial NCT05181124 · COMPLETED

Trial details

NCT number: NCT05181124
Sponsor: Onconic Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anti-Ulcer Agents

Start date: 2021-03-05
Primary completion: 2021-03-15
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.